About Organon

Organon operates as an independent pharmaceutical company focused on advancing women's health. The company delivers more than 70 medicines and devices addressing reproductive health, maternal care, contraception, fertility, cardiovascular disease, and bone health. With a portfolio spanning women's health innovations, biosimilars, and established therapies, Organon works to close therapeutic gaps that have historically underfunded women. Spun off from Merck in 2021, Organon operates with entrepreneurial focus on populations where women face disproportionate health challenges. The company concentrates on expanding access to treatments that improve daily health outcomes for women, families, and communities worldwide.